About Us
Medical Blog
  • Myriad Genetics Announces an Assay that Identifies Patients for Olaparib Treatment

    Salt Lake City-based Myriad Genetics, Inc. announced that its BRACAnalysis CDx® test accurately identifies patients with ovarian cancer for a second-line treatment with olaparib. The announcement came as a result of a clinical study finding that the Myriad diagnostic device accurately identifies patients for olaparib treatment. Commenting on the results of the clinical study, Johnathan Lancast ...
  • Isto Holdings Acquires Arteriocyte To Form Isto Biologics

    Isto Holdings, the parent company of Isto Technologies, has acquired Massachusetts based Arteriocyte Medical Systems Inc. and the two companies will be combined under the name Isto Biologics under the current CEO of Isto Technologies, George Dunbar. According to its website, Isto Technologies is a medical device company involved with bone and cartilage repair and regeneration. Public records ...
  • 2016 Security of Things® Forum

    The third annual Security of Things® Forum (SECOT) in Cambridge, Massachusetts fostered discussion on a variety of cyber-security related topics ranging from a standards-based approach to security connected devices to connected healthcare platforms.  Even the Department of Homeland Security weighed in on its own efforts to influence the next generation of connected networked devices by developin ...
Conferences